NCT02503865

Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome

Phase 1-2 Study of Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 351 (actual)
• Sponsor: Nazarbayev University · Academic / Other
• Sex: All
• Age: 25 Years – 74 Years
• Healthy volunteers: Accepted

Summary

Metabolic syndrome: aetiology, pathogenesis, diagnosis, clinical management and prognosis

Detailed description

Purpose: To create the complex scientifically proved concept of Metabolic syndrome (МS) development based on elaboration of the new methods of clinical diagnostics of МS components and highly effective МS clinical management in comparative studying of clinical, laboratory and cost effectiveness. Participants and methods: This clinical study included 351 adults (184 female) in the Scientific research institute of cardiology and internal diseases (Almaty, the Republic of Kazakhstan). Statistical analysis was performed using Microsoft Excel-2008 in updating Lapach, Chubenko et al (2000) and SPSS for Windows v.17.0.

Conditions

• Metabolic Syndrome

Interventions

Type	Name	Description
DRUG	Xenical, Pionorm, Diroton, Diltiazem, Atorvastatin	Xenical (Orlistat) - 120 mg/day in integration of Pionorm (Pioglitazone hydrochlorid) - 30 mg/day, Diroton (Lizinopril) - 20 mg/day, Diltiazem - 90 mg/day, Atorvastatin (Liprimar) - 40 mg/day
DIETARY_SUPPLEMENT	"Analimentary detoxication"	Vegetable and salt diet

Timeline

• Start date: 2003-01-01
• Primary completion: 2008-12-01
• Completion: 2014-12-01
• First posted: 2015-07-21
• Last updated: 2015-11-30
• Results posted: 2015-11-03

Locations

1 site across 1 country: Kazakhstan